Company intelligence / Profile preview

Duchesnay

Blainville, Quebec, Canadasepaq.com ↗

Ownership: Private
Development stage: Commercial

Overview

Duchesnay has a long-standing focus on women’s health, offering approved therapies for conditions such as nausea and vomiting of pregnancy and menopausal symptoms. Its lead products are commercialized in over 40 countries. The company’s combination therapy for morning sickness has a strong safety record spanning four decades. Recent regulatory approvals have expanded its reach globally.

Therapeutic areas: Women's HealthUrology
Modalities: Small molecules
Industry: Biotech

Drug pipeline

3 assets

PregVit Folic

2 more assets in the full pipeline.

Request access →

Partnerships

Strategic alliances in over fifty countries; specific partners not named but includes global distribution partners.

Beyond the preview

Go deeper on Duchesnay.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Duchesnay.

Explore the full profile